Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.27 - $2.28 $5 - $9
-4 Reduced 0.01%
61,391 $79,000
Q2 2023

Aug 14, 2023

SELL
$1.44 - $2.19 $162 - $247
-113 Reduced 0.18%
61,395 $105,000
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $34,595 - $79,836
29,569 Added 92.58%
61,508 $111,000
Q2 2022

Aug 15, 2022

BUY
$3.03 - $5.32 $96,775 - $169,915
31,939 New
31,939 $116,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.